B

BioAdvance

31 employees

BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.

Investor insights

Countries invested in

united states3

Sectors invested in

Biotechnology105
Health Care80
Pharmaceutical57
Medical35
Biopharma26
Health Diagnostics24
Therapeutics16
Information Technology13
drug discovery12
Clinical Trials11
Analytics11
antivirals10
HIV8
hepatitis b8
First-in-class targeted oncology drug development8
Hospital8
Life Science7
Pharma QC7
Analytical Instrumentation7
Medical Device6

Funding rounds participated in

$3.3M sweet spot round size

Most of their 179 investments are in rounds between $592K and $10M

Investor type

Micro VC

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Financial Services
Life Science
Venture Capital

Date founded

2003

Investments made

K

KayoThera raised $5.2M on July 19, 2023

Investors: Pier 70 Ventures and BioAdvance

P

Palvella Therapeutics raised $38M on January 5, 2023

Investors: Samsara BioCapital, Nolan Capital, Inc., Gore Range Capital, -, Agent Capital and BioAdvance

S

Senzo Health raised $1.9M on December 12, 2022

Investors: Wellness Coaches and BioAdvance

I

Innervace raised $40M on September 8, 2022

Investors: Wisconsin Alumni Research Foundation, IP Group plc and BioAdvance

S

Senzo Health raised $2M on July 21, 2022

Investors: Wellness Coaches and BioAdvance

H

Halo Labs raised $7M on July 11, 2022

Investors: Research Corporation Technologies, Inc., BroadOak Capital Partners and BioAdvance

K

KayoThera raised $8M on March 16, 2022

Investors: 7G BioVentures and BioAdvance

W

Wellsheet raised $3.8M on June 11, 2020

Investors: Beni VC | Your partners in growth, Newark Venture Partners, SpringTide Ventures and BioAdvance

P

Palvella Therapeutics raised $45M on May 28, 2020

Investors: Samsara BioCapital, Adams Street Partners, Agent Capital, Nolan Capital, Inc., Pharmacopeia now Ligand Pharmaceuticals and BioAdvance

H

Halo Labs raised $12M on April 6, 2020

Investors: BroadOak Capital Partners, Research Corporation Technologies, Inc. and BioAdvance

FAQ